Claritev Corp. (CTEV)
39.39
+0.61
(+1.57%)
USD |
NYSE |
Aug 28, 16:00
39.37
-0.02
(-0.05%)
Pre-Market: 20:00
Claritev Cash from Operations (Quarterly) : 92.67M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.67M |
| March 31, 2026 | -45.78M |
| December 31, 2025 | 66.29M |
| September 30, 2025 | 19.86M |
| June 30, 2025 | 65.50M |
| March 31, 2025 | -34.32M |
| December 31, 2024 | -34.03M |
| September 30, 2024 | 72.84M |
| June 30, 2024 | 18.47M |
| March 31, 2024 | 49.72M |
| December 31, 2023 | 27.70M |
| September 30, 2023 | 72.12M |
| June 30, 2023 | 7.685M |
| Date | Value |
|---|---|
| March 31, 2023 | 64.22M |
| December 31, 2022 | 27.69M |
| September 30, 2022 | 109.04M |
| June 30, 2022 | 40.70M |
| March 31, 2022 | 194.94M |
| December 31, 2021 | 33.26M |
| September 30, 2021 | 167.04M |
| June 30, 2021 | 33.48M |
| March 31, 2021 | 170.91M |
| December 31, 2020 | 45.07M |
| September 30, 2020 | 140.43M |
| June 30, 2020 | 44.47M |
| March 31, 2020 | 147.39M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| LataMed AI Corp. | -0.055M |
| SCWorx Corp. | -0.0057M |
| Health Catalyst, Inc. | 0.275M |
| GoodRx Holdings, Inc. | 80.83M |
| iSpecimen, Inc. | -0.6896M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -38.08M |
| Cash from Financing (Quarterly) | -61.64M |
| Free Cash Flow | -17.92M |
| Free Cash Flow Per Share (Quarterly) | 3.218 |
| Free Cash Flow to Equity (Quarterly) | 96.74M |
| Free Cash Flow to Firm (Quarterly) | 130.62M |
| Free Cash Flow Yield | -2.73% |